Merck & Co.’s newly approved oral drug works by generating mutations, raising hypothetical fears BY ROBERT F. SERVICE The first oral antiviral for treating COVID-19, Merck & Co.’s molnupiravir, received approval from the U.K. Medicines and Healthcare products...
A prominent virologist warns COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm
read more